-transparent.png){kind=logo}
Renal osteodystrophy in part due to secondary hyperparathyroidism, is one of the major unresolved problems affecting patients on chronic hemodialysis. In addition, evidence has shown that parathyroid hormone (PTH) is toxic to other organ systems besides bone. The results of a prospective study on the effect of propranolol in reducing PTH levels in chronic renal failure patients on hemodialysis are reported. Propranolol administration reduced PTH levels by over 50-75%. The levels of calcium, phosphorus, alkaline phosphatase and hematocrit were variable, but patients with severe derangements in these measurements also seemed to benefit from propranolol. It should now be determined by larger and longer studies whether these biochemical improvements can be translated into clinical benefits.
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
February 1979,
JAMA,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
January 1999,
Laeknabladid,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
October 2001,
Clinical calcium,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
July 1955,
Proceedings of the Royal Society of Medicine,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
January 1983,
Scandinavian journal of urology and nephrology. Supplementum,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
January 1981,
Annals of clinical and laboratory science,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
January 1972,
Acta medica Iugoslavica,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
June 1983,
Israel journal of medical sciences,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
April 1995,
Nihon rinsho. Japanese journal of clinical medicine,
A Besarab, and
J F Caro, and
B U Ihle, and
J F Burke, and
J A Glennon, and
J A Fischer
April 2011,
Nephrologie & therapeutique,
